Profile
Theresa Mansi is associated with NexEos Diagnostics, Inc. and NexEos Bio, Inc. as the Chief Executive Officer and Director, and Chief Executive Officer respectively.
Theresa Mansi active positions
Companies | Position | Start |
---|---|---|
NexEos Diagnostics, Inc.
NexEos Diagnostics, Inc. Medical/Nursing ServicesHealth Services NexEos Diagnostics, Inc. operates as a medical diagnostics company focuses on disorders related to white blood cells. The company is headquartered in Wayne, PA. | Chief Executive Officer | - |
NexEos Bio, Inc.
NexEos Bio, Inc. Medical/Nursing ServicesHealth Services NexEos Bio is a medical diagnostics company that aims to improve the detection, diagnosis, treatment, and management of patients with chronic, eosinophil-related inflammatory diseases. The company is based in Wayne, PA. The company's lead program is a non-invasive imaging agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis (EoE). This program has the potential to improve patients' quality of life, more rapidly diagnose their disease, and may help delay disease progression. The company was founded by Gerald Gleich, and the CEO is Theresa Mansi. | Chief Executive Officer | - |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 2 |
---|---|
NexEos Diagnostics, Inc.
NexEos Diagnostics, Inc. Medical/Nursing ServicesHealth Services NexEos Diagnostics, Inc. operates as a medical diagnostics company focuses on disorders related to white blood cells. The company is headquartered in Wayne, PA. | Health Services |
NexEos Bio, Inc.
NexEos Bio, Inc. Medical/Nursing ServicesHealth Services NexEos Bio is a medical diagnostics company that aims to improve the detection, diagnosis, treatment, and management of patients with chronic, eosinophil-related inflammatory diseases. The company is based in Wayne, PA. The company's lead program is a non-invasive imaging agent for the diagnosis, treatment monitoring, and management of eosinophilic esophagitis (EoE). This program has the potential to improve patients' quality of life, more rapidly diagnose their disease, and may help delay disease progression. The company was founded by Gerald Gleich, and the CEO is Theresa Mansi. | Health Services |
- Stock Market
- Insiders
- Theresa Mansi